Cargando…
1617P Sustained cancer clinical trial activity during the COVID-19 pandemic
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454374/ http://dx.doi.org/10.1016/j.annonc.2021.08.1610 |
| _version_ | 1784570478538522624 |
|---|---|
| author | Bayle, A. Baldini, C. Romano, P. Martin Michot, J-M. Champiat, S. Bahleda, R. Gazzah, A. Marabelle, A. Verlingue, L. Geraud, A. Morel, D. Michiels, S. Ribrag, V. Hollebecque, A. Albiges, L. Besse, B. Soria, J-C. Massard, C. Barlesi, F. Postel-Vinay, S. |
| author_facet | Bayle, A. Baldini, C. Romano, P. Martin Michot, J-M. Champiat, S. Bahleda, R. Gazzah, A. Marabelle, A. Verlingue, L. Geraud, A. Morel, D. Michiels, S. Ribrag, V. Hollebecque, A. Albiges, L. Besse, B. Soria, J-C. Massard, C. Barlesi, F. Postel-Vinay, S. |
| author_sort | Bayle, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454374 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543742021-09-21 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic Bayle, A. Baldini, C. Romano, P. Martin Michot, J-M. Champiat, S. Bahleda, R. Gazzah, A. Marabelle, A. Verlingue, L. Geraud, A. Morel, D. Michiels, S. Ribrag, V. Hollebecque, A. Albiges, L. Besse, B. Soria, J-C. Massard, C. Barlesi, F. Postel-Vinay, S. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454374/ http://dx.doi.org/10.1016/j.annonc.2021.08.1610 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Bayle, A. Baldini, C. Romano, P. Martin Michot, J-M. Champiat, S. Bahleda, R. Gazzah, A. Marabelle, A. Verlingue, L. Geraud, A. Morel, D. Michiels, S. Ribrag, V. Hollebecque, A. Albiges, L. Besse, B. Soria, J-C. Massard, C. Barlesi, F. Postel-Vinay, S. 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic |
| title | 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic |
| title_full | 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic |
| title_fullStr | 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic |
| title_full_unstemmed | 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic |
| title_short | 1617P Sustained cancer clinical trial activity during the COVID-19 pandemic |
| title_sort | 1617p sustained cancer clinical trial activity during the covid-19 pandemic |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454374/ http://dx.doi.org/10.1016/j.annonc.2021.08.1610 |
| work_keys_str_mv | AT baylea 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT baldinic 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT romanopmartin 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT michotjm 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT champiats 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT bahledar 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT gazzaha 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT marabellea 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT verlinguel 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT gerauda 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT moreld 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT michielss 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT ribragv 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT hollebecquea 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT albigesl 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT besseb 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT soriajc 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT massardc 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT barlesif 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic AT postelvinays 1617psustainedcancerclinicaltrialactivityduringthecovid19pandemic |